 The Diabetes Control and Complications Trial DCCT showed that improving blood sugar control for individuals with Type 1 diabetes T1DM stopped or delayed the onset of long-term complications. As a result of the study, intensive insulin management is aimed to control blood sugar and glycosylated hemoglobin 3 month blood glucose average test as near to normal as safely possible. However, hypoglycemia low blood sugar was increased three fold in the DCCT study and is the major limiting factor in gaining tight control of blood sugar in T1DM. 